Akemi Kurisu

4 ta ish

Hiroshima University

1. Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

   Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima +13

   MaqolaOAOchiq kirishSARS-CoV-2 and COVID-19 ResearchScientific Reports20221 iqtibos

   ABIABI:AkademIndex/2022.article.000606

2. Variant-specific Symptoms After COVID-19: A Hospital-based Study in Hiroshima

   Kanon Abe, Aya Sugiyama, Noriaki Ito +11

   MaqolaOAOchiq kirishLong-Term Effects of COVID-19Journal of Epidemiology20230 iqtibos

   ABIABI:AkademIndex/2023.article.001479

3. Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

   Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima +13

   BoshqaOAOchiq kirishImmunotherapy and Immune ResponsesScientific Reports20230 iqtibos

   ABIABI:AkademIndex/2023.other.000020

4. Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐2

   Serge Ouoba, Aya Sugiyama, Ko Ko +11

   MaqolaOAOchiq kirishSARS-CoV-2 detection and testingJournal of Medical Virology20240 iqtibos

   ABIABI:AkademIndex/2024.article.002118